Yung-Ping  Yeh net worth and biography

Yung-Ping Yeh Biography and Net Worth

Insider of Vyant Bio
Ping co-founded StemoniX in April 2014 and, since then, has served as its Chief Executive Officer and a Board Member. He cofounded the company after surviving blood cancer in 2013 - an experience that was the impetus for wanting to leverage his background in engineering, softare and manufacturing to find safer and more effective medicines for patients. Prior to co- founding StemoniX, Mr. Yeh commercialized multiple technologies to the tech industry. Highlights include serving as team lead for the first solid state drive product for Seagate Technology, leading the global partnership between Samsung and Seagate to create new flash technology and program managing the operating system software development for Dell enterprise storage systems. Mr. Yeh has successfully led through a multi-disciplinary approach for the last two decades of his career. Mr. Yeh holds a bachelor of science and master’s degree in mechanical engineering (nanotechnology emphasis) from University of California, San Diego, and a master’s degree in business administration from University of Minnesota’s Carlson School of Management. He has attained professional certifications in program and project management from the Project Management Institute and Mergers and Acquisitions from Northwestern’s Kellogg School of Management. Mr. Yeh serves on the UC San Diego Alumni Board of Directors and Medical Alley Board of Directors.

What is Yung-Ping Yeh's net worth?

The estimated net worth of Yung-Ping Yeh is at least $2,378.83 as of August 25th, 2021. Mr. Yeh owns 12,262 shares of Vyant Bio stock worth more than $2,379 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Yeh may own. Additionally, Mr. Yeh receives an annual salary of $22,500.00 as Insider at Vyant Bio. Learn More about Yung-Ping Yeh's net worth.

How old is Yung-Ping Yeh?

Mr. Yeh is currently 47 years old. There are 1 older executives and no younger executives at Vyant Bio. The oldest executive at Vyant Bio is Mr. Andrew D.C. LaFrence CPA, President, CEO & CFO, who is 60 years old. Learn More on Yung-Ping Yeh's age.

What is Yung-Ping Yeh's salary?

As the Insider of Vyant Bio, Inc., Mr. Yeh earns $22,500.00 per year. The highest earning executive at Vyant Bio is Mr. Andrew D.C. LaFrence CPA, President, CEO & CFO, who commands a salary of $407,400.00 per year. Learn More on Yung-Ping Yeh's salary.

How do I contact Yung-Ping Yeh?

The corporate mailing address for Mr. Yeh and other Vyant Bio executives is 2370 State Route 70 Suite 310, Cherry Hill NJ, 08002. Vyant Bio can also be reached via phone at (201) 479-1357 and via email at [email protected]. Learn More on Yung-Ping Yeh's contact information.

Has Yung-Ping Yeh been buying or selling shares of Vyant Bio?

Yung-Ping Yeh has not been actively trading shares of Vyant Bio within the last three months. Most recently, on Monday, November 22nd, Yung-Ping Yeh bought 500 shares of Vyant Bio stock. The stock was acquired at an average cost of $2.05 per share, with a total value of $1,025.00. Learn More on Yung-Ping Yeh's trading history.

Who are Vyant Bio's active insiders?

Vyant Bio's insider roster includes Marcus Boehm (Director), R. Fletcher (Director), Paul Hansen (Director), John Roberts (CEO), and Yung-Ping Yeh (Insider). Learn More on Vyant Bio's active insiders.

Yung-Ping Yeh Insider Trading History at Vyant Bio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2021Buy500$2.05$1,025.00View SEC Filing Icon  
8/25/2021Buy1,000$2.64$2,640.0012,262View SEC Filing Icon  
See Full Table

Yung-Ping Yeh Buying and Selling Activity at Vyant Bio

This chart shows Yung-Ping Yeh's buying and selling at Vyant Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vyant Bio Company Overview

Vyant Bio logo
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey.
Read More

Today's Range

Now: $0.19
Low: $0.18
High: $0.20

50 Day Range

MA: $0.19
Low: $0.19
High: $0.19

2 Week Range

Now: $0.19
Low: $0.14
High: $1.58

Volume

19,100 shs

Average Volume

161,822 shs

Market Capitalization

$1.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.73